LILRB1 has been reported to exert an immunoregulatory effect via interacting with a wide spectrum of HLA class I molecules [33], thus meditating tumor cell eradication and optimistic prognosis (Supplementary Fig. 5e). The gene discussed is LILRB1; the disease is neoplasm.